is tirzepatide banned WADA just added (mounjaro) to the 2026 Monitoring Program What you need to know

This could simplify initial treatment regimens while providing additional benefits for weight management and potentially cardiovascular risk reduction

Microdosing Tirzepatide offers a gentler ramp-up that supports long-term compliance, preserves patient comfort, and allows for adjustments based on real-world results

You need baseline labs, periodic monitoring, and a provider who can intervene if something goes wrong

However, retatrutide is not yet licensed in the UK and these findings require confirmation in larger, longer-term studies

Heres a closer look at the key benefits: 1

The initial weeks of tirzepatide therapy represent an adjustment period during which patients should anticipate both therapeutic effects and potential adverse reactions